Skip to content
IPC_HH_2025_L6A3551

CONFERENCE SPEAKERS & PROGRAM

THEMES & CONFIRMED SPEAKERS

Theme 1: Gaps in Glomerular Disease Clinical Trials: Where Are We Today?

Brad Rovin, The Ohio State University

Jonathan Barratt, University of Leicester

Laurel Damashek, International Society of Glomerular Disease

Liz Lightstone, ISN President-Elect, Imperial College London

Marina Vivarelli, Bambino Gesù Children's Hospital, IRCCS

Theme 2: Emerging Biomarkers and Treatment Targets in GD Clinical Trials

Alexander Duncan, Walden Biosciences

Alice Brown, PureSpring Therapeutics

Jonathan Hogan, Cabaletta Bio

Laura Mariani, University of Michigan

Nicola Tomas, UKE Hamburg

Vineet Gupta, UTMB

Theme 3: Past Lessons and Future Vision

Ana Malvar, University of Buenos Aires

Daniel Gale, University College London

Hiddo Heerspink, University Medical Center Groningen

Katherine Tuttle, Providence Health Care, University of Washington

Kirk Campbell, NKF President, University of Pennsylvania

Matthias Kretzler, University of Michigan

Meg Jardine, University of Sydney

Muh Geot Wong, University of Sydney

Patrick Nachman, University of Minnesota

Sean Barbour, University of British Columbia

Suceena Alexander, Christian Medical College, Vellore

Vlado Perkovic, UNSW Sydney

Theme 4: Regulatory Advances

Abigail Smith, Northwestern University

Alex Mercer, JAMCO Pharma Consulting

Barbara Gillespie, International Society of Glomerular Disease, University of North Carolina

Brendon Neuen, The George Institute for Global Health

Eloise Salmon, University of Michigan

Hiddo Heerspink, University Medical Center Groningen

Jochen Reiser, UTMB

Lesley Inker, Tufts University School of Medicine

Louise Oni, University of Liverpool, UCL and Great Ormond Street Hospital for Children

Priya Verghese, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University

Tom Greene, University of Utah Health

Vlado Perkovic, UNSW Sydney

Theme 5: Breaking Barriers for Successful Trial Recruitment and Execution

Barbara Gillespie, International Society of Glomerular Disease, University of North Carolina

Josh Tarnoff, NephCure

Jula Inrig, Travere Therapeutics

Jule Pinter, UKE Hamburg

Shikha Wadhwani, UTMB

Susan Brisendine, NephCure

Sydney Tang, University of Hong Kong

Tobias B. Huber, International Society of Glomerular Disease, UKE Hamburg

Uptal Patel, Biogen

AGENDA HIGHLIGHTS

Subject to change; full agenda forthcoming
  • Day 1: Friday Nov 13
  • Day 2: Saturday Nov 14
  • Day 3: Sunday November 15

10:30 am

PROGRAM BEGINS

Gaps in Glomerular Disease Clinical Trials: Where Are We Today?

Highlights from 2025-26 Conferences

Voice of the Patient

Emerging Biomarkers & Treatment Targets in GD Clinical Trials

  • Gene Delivery to the Podocyte
  • Cellular Therapy and Bispecific Antibodies for GD

Voice of Pharma: Translating Science into Therapeutics (Panel)

Past Lessons and Future Vision for GD Trials

  • Lessons Learned in Past GD trials
  • Evolving Trial Design & Endpoints

5:45 PM

PROGRAM ENDS

8:00 am

PROGRAM BEGINS

Voice of the FDA: What Keeps Us Up at Night (Panel)

Unmet Needs in Other Patient Populations

  • Pediatric Extrapolation
  • Trials in Transplant Patients

Should the Trial Proceed? DSMB Dilemmas

Voice of Healthcare Institutions' Leaders (Panel)

Poster Sessions

4:15 pm

PROGRAM ENDS

9:00 am

PROGRAM BEGINS

Breaking Barriers for Successful TrialRecruitment & Execution

  • GD Centers of Excellence
  • Recruiting More than 1 Patient at Each Site
  • Trial Operations Solutions

Voice of Pharma's C-Suite: What Keeps Us Up at Night (Panel)

Late Breaking Research

Voice of the Clinical Trials Village (Panel)

1:00 pm

PROGRAM ENDS